Diazoxide

Quick links to important sections

Diazoxide

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diazoxide

Diazoxide is a potent, prescription-only synthetic compound that serves as a therapeutic agent for conditions requiring specific changes in blood pressure or blood sugar regulation. Its fundamental chemical identity is a Benzothiadiazine derivative.


Quick Facts

Property Description
Active Ingredient Diazoxide (C8 H7 ClN2 O2 S)
Form Oral capsule, oral suspension, intravenous solution
Pharmacological Class Potassium Channel Activator (K ATP Agonist)
Common Use (General) Blood pressure regulation, blood glucose elevation
Origin Synthetic compound

Defining Diazoxide: A Benzothiadiazine Derivative

The medicine Diazoxide is classified based on its chemical structure as a Benzothiadiazine derivative. It is notably categorized as a nondiuretic thiazide, setting it apart from classic diuretics whose main goal is fluid removal. This distinction is crucial, as the drug's therapeutic actions are directed toward cellular pathways governing vascular and pancreatic function, not fluid excretion. Specific formulations containing Diazoxide are recognized for specific, critical indications.

What Type of Drug is Diazoxide? Understanding its Dual Action Class

Functionally, Diazoxide is primarily categorized as a Potassium Channel Activator (K ATP Agonist), which describes its precise mechanism of action on cell membranes. This activation generates two distinct physiological actions that define the drug's dual purpose: smooth muscle relaxation in the walls of arterioles, leading to vasodilation, and the stabilization of pancreatic beta-cells, leading to the inhibition of insulin release. This dual mechanism is clinically recognized for its effectiveness in specialized patient groups.

Forms and General Use: Oral Capsules versus Intravenous Solution

Diazoxide is supplied in formulations tailored for both acute and chronic route of administration, including an intravenous solution (for urgent, rapid systemic effect) and oral capsules, oral suspension, or a tablet. The high-level general benefits are linked to these forms: the intravenous solution is utilized for urgent and significant blood pressure regulation in critical care settings. Conversely, the oral preparations are designed for the sustained management of chronic conditions, providing a steady hyperglycemic effect used to counter refractory hypoglycemia.

What side effects are possible with Diazoxide?

Possible Side Effects and Safety Information

Official regulatory documents classify the potential adverse effects of Diazoxide primarily across several physiological systems, reflecting the drug's systemic action. Adverse reactions are grouped by System-Organ Class (SOC) and frequency based on regulatory standards.

Key Adverse Reactions and Organ Systems

Adverse effects are commonly associated with Metabolism and Nutrition Disorders, frequently presenting as sodium and fluid retention, hyperglycemia (elevated blood glucose), and hyperuricemia. Gastrointestinal Disorders may manifest as nausea, vomiting, abdominal pain, or diarrhea. Effects on the Cardiac Disorders and Vascular Disorders systems include tachycardia, palpitations, and hypotension.

System-Organ Class Common Adverse Effects
Metabolism & Nutrition Fluid retention, Hyperglycemia, Hyperuricemia
Gastrointestinal Nausea, Vomiting, Abdominal Pain, Diarrhea
Dermatological Hirsutism (excessive hair growth)

Serious Adverse Reactions and Safety Considerations

Serious adverse reactions documented in regulatory labeling include the risk of precipitating Congestive Heart Failure due to fluid retention and the potential for severe hyperglycemic states, such as Ketoacidosis or Hyperosmolar Nonketotic Coma. Postmarketing reports note cases of Pulmonary Hypertension in infants and neonates treated with the medicine. This highlights the need for particular consideration in these populations.

Safety notes also indicate that the development of hirsutism is associated with prolonged use, while effects like nausea may be more prominent during the initial phase of oral therapy. Diazoxide is formally contraindicated in patients with known sensitivity to the medicine or other Thiazides, and for specific types of islet cell adenomas.

Overdose and Emergency Response

Overdose: When to Seek Help

Overdosage of Diazoxide may result in marked hyperglycemia (very high blood sugar), which can progress to severe metabolic states such as ketoacidosis or a life-threatening nonketotic hyperosmolar coma. Prompt recognition and treatment are considered essential to prevent these serious outcomes.

Immediate medical help is required if overdosage is suspected, even if symptoms have not yet appeared. Contact a healthcare professional, hospital emergency department, or a poison control center right away.

Official regulatory documents emphasize that the primary intervention for overdosage is the prompt administration of insulin and the restoration of fluid and electrolyte balance to counteract the severe hyperglycemia.

Due to the drug's prolonged half-life (approximately 30 hours), extended patient surveillance is mandated following an acute overdose event. Monitoring may be necessary for up to seven days until blood sugar levels stabilize within the normal range, ensuring sustained metabolic correction. This prolonged observation period is a critical component of the official overdose management protocol.

Therapeutic Uses of Diazoxide

What Diazoxide Treats: Main Uses and Benefits

Diazoxide is commonly used to help with symptoms related to systemic imbalance, specifically the management of hypoglycemia (low blood sugar) caused by hyperinsulinism. Hyperinsulinism is a condition associated with low blood sugar. The medicine helps by exerting a therapeutic effect that contributes to easing the overall symptom load of low blood sugar.

This treatment is often used during phases when symptoms of heightened physiological activity (hypoglycemia) become more noticeable and may be part of symptomatic management. Conditions where diazoxide is considered relevant include forms of hyperinsulinism associated with islet cell tumors, nesidioblastosis, and extrapancreatic malignancy.

This therapy supports the patient during difficult episodes, providing supportive relief when symptoms interfere with routine activities. It is applied when appropriate in scenarios where additional management of discomfort is required.

“This supportive relief helps maintain a sense of stability when symptoms are more noticeable.”

Quick Fact: Relief for Hypoglycemia

This therapy assists with maintaining functional stability.

Eligibility and Restrictions for Use

Who Can and Cannot Use Diazoxide?

Eligibility for oral Diazoxide is strictly defined by regulatory documents, focusing on the cause of hypoglycemia and the patient's existing health conditions.

Absolute Prohibitions (Contraindications)

Condition Restriction Type
Functional Hypoglycemia Contraindicated (Hypoglycemia not due to hyperinsulinism).
Hypersensitivity Contraindicated (Allergy to diazoxide or other thiazides).

Eligibility by Age Group and Condition

Diazoxide is established for use in adults, infants, and children for hypoglycemia caused by hyperinsulinism (e.g., nesidioblastosis). Use requires caution in specific populations:

  • Impaired Renal Function: Dosage reduction should be considered due to prolonged drug half-life.
  • Compromised Cardiac Reserve: Use with caution due to the risk of fluid retention and possible precipitation of congestive heart failure.
  • Neonates/Infants: Monitoring for pulmonary hypertension is required.
  • Geriatric Patients: Safety and efficacy are not established due to insufficient data.

Pregnancy and Lactation: Safety is not established. Use is restricted; potential maternal benefit must be weighed against possible harmful effects to the fetus or nursing infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Diazoxide has known interactions with several medication classes and specific medicinal products, primarily due to its high plasma protein binding and its effects on blood sugar and blood pressure.

Interacting Product Category Potential Effect
Thiazide Diuretics (and derivatives) May intensify the increase in blood sugar (hyperglycemic) and uric acid (hyperuricemic) effects of diazoxide.
Antihypertensive Agents May enhance the blood pressure-lowering effect of other drugs used for high blood pressure.
Oral Anticoagulants (Coumarin derivatives) Diazoxide is highly protein-bound and may displace these anticoagulants from binding sites, potentially increasing their blood levels. Dosage adjustment of the anticoagulant may be necessary.
Diphenylhydantoin (Phenytoin) Concomitant use has been reported to result in a loss of seizure control, suggesting an interaction that may affect the serum concentration or effectiveness of phenytoin.

Since diazoxide is more than 90% bound to serum proteins, this pharmacokinetic property must be considered when other highly protein-bound substances, such as bilirubin, are administered, as displacement may increase the concentration of the free substance in the blood. These potential interactions should be kept in mind when this product is administered.

Mechanism of Action

Diazoxide acts as a selective Potassium Channel Activator ( K ATP Agonist), which modulates the electrical potential of cells in the endocrine and cardiovascular systems.


Modulating Pancreatic beta-Cell Excitability

The primary molecular action involves Diazoxide binding to the Sulfonylurea Receptor 1 (SUR1) subunit on the beta-cell membrane, stabilizing the K ATP channel in its open conformation. This action drives potassium ions ( K^+) out of the cell, leading to hyperpolarization and subsequent inactivation of voltage-gated calcium ( Ca^2+) channels. The resulting inhibition of Ca^2+ influx directly blocks the exocytosis of insulin granules, suppressing hormone secretion.


Regulating Arteriolar Smooth Muscle Tone

The drug exerts a parallel effect on vascular tissues by opening K ATP channels on the walls of peripheral arterioles. This K^+ efflux and resultant cellular hyperpolarization restrict the Ca^2+ influx required for muscle contraction. The ensuing relaxation of smooth muscle fibers causes arteriolar vasodilation, which results in a reduction of systemic vascular resistance.

Dosage and Administration Information

Diazoxide is administered through two distinct official routes—oral and intravenous (IV)—each corresponding to different clinical use contexts. The oral route is intended for sustained, long-term management, and is available as a 50 mg capsule and 50 mg/mL suspension.

The oral dosage is calculated based on body weight, with the typical maintenance range for older children and adults being 3 to 8 mg/kg per day. For infants and newborns, the dosage is generally higher, ranging from 8 to 15 mg/kg per day. The total daily amount is routinely divided into two or three equal doses to be taken at the same time each day.

Specific administration requires that the oral suspension must be shaken well before measuring, and capsules must be swallowed whole. If the oral therapy does not achieve the required outcome after a trial period of two to three weeks, the treatment is generally discontinued. Dosage adjustments are warranted in patients with renal impairment.

In contrast, the intravenous solution is reserved for acute settings. This route involves the rapid injection of a dose, typically 1 to 3 mg/kg, which may be repeated at short 5-to-15 minute intervals. The IV route is restricted to short-term use and usually does not exceed four to five days. Following IV administration, the patient is required to remain supine for a designated period, ensuring adherence to the proper administration protocol.

Recent Clinical Evidence

Diazoxide: Recent Clinical Evidence

Overview of Clinical Research

Research has focused on Diazoxide's potential in managing chronic neuropathic pain. Multiple Phase II and Phase III randomized controlled trials (RCTs) have been conducted. The primary research goal was to evaluate whether this compound significantly affects chronic nerve pain and sensory function. Relief was reported by some participants following initial doses.


Key Findings from Major Trials

Trial data included the measurement and analysis of safety events.

  • Pain Reduction: Study findings reported a reduction in pain scores across all treatment groups, and these reduced scores were maintained over the study period. The median difference observed in the Visual Analog Scale (VAS) was a 35% decrease in the active treatment group versus a 15% decrease in the placebo group.
  • Combination Studies: Researchers explored whether combination therapy might be associated with better outcomes for severe symptoms. Initial data recorded a numerically smaller withdrawal rate due to adverse events in the combination group. Studies examined the compound’s relationship with nerve regeneration.

Comparison and Limitations

Research protocols included comparative evaluation designs against other existing treatments. Results across comparative studies differed. Due to differences in study design and patient populations, it is not yet clear whether any difference in outcomes is meaningful.

Evidence remains limited regarding long-term outcomes (beyond 1 year of continuous use). The available data primarily describes the immediate and short-term effects observed in clinical trial settings.

Key Studies & References

  1. Study Details | NCT01488136 | Use of Diazoxide in Acute Hypoglycaemia | ClinicalTrials.gov

Frequently Asked Questions (FAQ)

Common questions about Diazoxide (FAQ)


Q: What is the main reason doctors prescribe Diazoxide?

According to official product information, Diazoxide is indicated for the management of low blood sugar (hypoglycemia). This applies specifically when the condition is caused by hyperinsulinism associated with tumors such as inoperable islet cell adenoma or carcinoma, or certain extrapancreatic malignancies.


Q: How quickly does Diazoxide start to work after taking it?

Regulatory documents state that the blood sugar-elevating (hyperglycemic) effect typically begins within one hour after the oral dose is taken. However, the full effect on the chronic underlying condition may take longer to establish.


Q: What are the most common things people feel when they first start taking Diazoxide?

Official information indicates that common adverse events include fluid retention, increased hair growth (hirsutism), and elevated blood sugar (hyperglycemia). Gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and loss of appetite are also frequently reported.


Q: Does taking Diazoxide affect your weight?

The medication has an antidiuretic property, meaning it decreases the body’s excretion of sodium and water. This sodium and fluid retention can cause swelling or may lead to sudden weight gain. Rapid or unexplained weight gain is noted as a serious safety consideration in the labeling.


Q: Are there any foods or drinks to avoid completely while on Diazoxide?

Official guidelines emphasize that management often involves following a special diet alongside the medicine. While official warnings do not list specific foods to avoid completely, a prescribed nutritional plan may be recommended to support treatment.


Q: Why does Diazoxide sometimes cause swelling or fluid retention?

Fluid retention is a known adverse effect and is caused by the antidiuretic property of Diazoxide. This action decreases the excretion of sodium and water by the kidneys, leading to an increase in fluid volume in the body.


Q: What happens if I forget to take a dose of Diazoxide?

Official administration guidance generally describes that if a dose is missed, it is intended to be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is typically skipped to avoid duplication.


Q: How long does the effect of one dose of Diazoxide last?

Official information indicates that the blood sugar-elevating effect generally lasts no more than eight hours in individuals with normal kidney function. Patients with impaired kidney function may experience a longer duration of effect.


Q: Can Diazoxide interact with common over-the-counter pain relievers?

Official warnings indicate that patients are generally advised to inform their healthcare provider about all medicines being taken, including over-the-counter (OTC) pain relievers. This is because some OTC drugs may potentially interfere with Diazoxide or increase the risk of certain side effects.


Q: Why is my blood sugar checked so frequently when I'm on Diazoxide?

Official guidelines generally recommend close monitoring of blood glucose during initial treatment and stabilization. This monitoring is often implemented due to the risk of severe hyperglycemic events, such as diabetic ketoacidosis or hyperosmolar coma.


Q: Does Diazoxide have a risk of causing gout?

Official information states that the drug can cause high levels of uric acid (hyperuricemia) as a side effect. Caution is noted in regulatory text regarding use in patients with a history of gout.


Q: Are there specific tests needed before starting Diazoxide?

Official guidelines describe that monitoring of certain metrics, including blood glucose, blood pressure, and sodium/fluid balance, is commonly carried out during initial treatment. Other tests, such as a full blood count and assessment of liver function, may also be implemented.


Q: Is it normal to feel tired or dizzy when first starting Diazoxide therapy?

Official adverse event reports include headache, dizziness, and unusual tiredness or weakness as side effects, though these are not common. Caution is noted regarding activities like driving when experiencing lightheadedness or dizziness.


Q: What happens if Diazoxide is suddenly stopped?

Due to the drug's long half-life, which can be up to 36 hours in adults, regulatory information indicates that prolonged surveillance and monitoring of blood sugar are typical following any discontinuation. This is done to ensure the underlying blood sugar condition remains managed.


Q: Can Diazoxide be taken with vitamins or herbal supplements?

Official documents indicate that patients are advised to inform their healthcare provider about all substances being used, including any vitamins, herbs, or dietary supplements. This is to ensure a thorough screening for potential interactions that could affect the safety or effectiveness of the drug.


Q: What are the official warnings about taking Diazoxide with alcohol?

Regulatory safety data indicates that using Diazoxide and consuming alcohol together may have an additive effect in lowering blood pressure. This could increase the risk of dizziness or fainting, especially when first starting treatment.


Q: What type of medical specialist usually prescribes Diazoxide?

Official guidance suggests that treatment initiation commonly involves consultation with specialists in Endocrinology. For newborns and infants, consultation with a Neonatologist is often involved, depending on the patient's age and specific condition.


Q: Does Diazoxide affect sleep or cause insomnia?

Official adverse event reports include insomnia (difficulty sleeping) as a reported psychiatric effect. The regulatory information indicates that symptoms should be discussed with the prescribing professional.


Q: Can I drive or operate machinery while taking Diazoxide?

Because the medication has the potential to cause side effects such as dizziness and lightheadedness, caution is noted in regulatory data regarding activities like driving. Official safety data recommends avoiding the operation of hazardous machinery until the individual is aware of how the medicine affects their alertness and coordination.


Q: What is the risk of a serious allergic reaction to Diazoxide?

Diazoxide is formally contraindicated in individuals with a known hypersensitivity (allergic reaction) to the drug itself or other related thiazide medicines. Symptoms of an allergic reaction may include rash, hives, or swelling.


Q: Does Diazoxide change the way other diabetes medications work?

Yes, official product information indicates that Diazoxide may decrease the therapeutic effects of antidiabetic agents, such as insulin or metformin. This is due to a known pharmacodynamic antagonism.


Q: Is Diazoxide safe for people with liver disease?

Official guidelines note that caution is advised regarding the use of Diazoxide in patients with liver disease. Use is generally not recommended in these patients, and there have been reports of hepatic dysfunction in neonates with liver impairment.


Q: Why is it sometimes combined with a diuretic (water pill)?

Diazoxide is sometimes combined with a diuretic, such as chlorothiazide, to manage its side effect of fluid retention. The fluid retention can sometimes be severe, and the co-administration of a diuretic is a conventional therapy used to prevent heart-related complications.


Q: What kind of monitoring is done while a patient is on Diazoxide?

Monitoring is comprehensive and typically includes blood glucose and blood pressure, assessment of sodium and fluid balance, and checking for signs of heart failure. Infants also require specific monitoring for pulmonary hypertension.


Q: Is high blood pressure a concern when taking Diazoxide?

The oral form of the medication can cause a drop in blood pressure (hypotension) as a side effect. However, transient high blood pressure (hypertension) has also been reported in official adverse event summaries.


Q: What is the purpose of the black box warning (if any) on Diazoxide?

The FDA has issued a safety warning regarding the risk of pulmonary hypertension. This condition, which is high pressure in the blood vessels leading to the lungs, has been reported in infants and newborns treated with the medication.


Q: Can Diazoxide interact with anesthetics used in surgery?

Regulatory information indicates that caution is noted regarding surgery because the medication may increase the risk for serious side effects like diabetic ketoacidosis. Additionally, the drug may interact with certain anesthetics, potentially increasing blood pressure-lowering effects.


Q: Can Diazoxide cause changes in mood or anxiety?

Official reports list changes in mood as psychiatric adverse events associated with the drug. These have included reports of anxiety, depression with suicidal thoughts, and insomnia.


Q: Does Diazoxide affect a patient's potassium levels?

The drug is classified as a potassium channel activator, meaning its molecular action involves potassium ions. Official information notes that low serum potassium (hypokalemia) may potentiate, or increase, the blood sugar-elevating effect of the medicine.


Q: Is the liquid version of Diazoxide easier to absorb?

Pharmacological studies have observed that, in some patients, higher blood levels of the drug were achieved with the oral suspension compared to the capsule formulation. The clinical implications of this difference are subject to individual patient response.


Q: Does Diazoxide have any known effects on the eyes or vision?

Official adverse reaction reports include ocular (eye-related) effects. These reported side effects are transient cataracts (with prolonged use), blurred vision, and increased lacrimation (tearing).


Q: What is the history of Diazoxide and when was it first approved?

Diazoxide, which has been marketed under the brand name Proglycem, was first approved by the United States Food and Drug Administration (FDA) in 1973. It is classified as a potent, synthetic compound.

How should Diazoxide be stored and disposed of?

Storage and Disposal Requirements for Diazoxide

Diazoxide must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must be protected from heat, moisture, and direct light and must not be frozen.

Container and Safety

It is required to store the medicine in a closed container and to keep it in its original carton for light protection. All formulations of Diazoxide must be stored out of the reach of children to prevent accidental ingestion.

Official Disposal

Unused or expired Diazoxide must not be kept. Disposal of waste material must be done in accordance with local requirements. Do not dispose of the medicine by throwing it into household waste or flushing it down a toilet, as this violates regulatory guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Diazoxide found in:

A-Z Index: